You are here


Founding Member

Elizabeth (Liz) Barrett

Chief Executive Officer, Novartis Oncology

Elizabeth (Liz) Barrett has been CEO of Novartis Oncology since February 1, 2018. She is a member of the Executive Committee of Novartis. 

Ms. Barrett previously served as global president of oncology at Pfizer Inc. Since joining Pfizer in 2009, she has held other leadership positions, including president of Global Innovative Pharma for Europe, president of the specialty care business unit for North America, and president of United States oncology. Prior to Pfizer, she was vice president and general manager of the oncology business unit at Cephalon Inc. from 2006 to 2009, and before that, she worked at Johnson & Johnson. She started her career at Kraft Foods Group Inc. in 1984.

Ms. Barrett holds a Bachelor of Science from the University of Louisiana and a Master of Business Administration from Saint Joseph’s University, both in the US.  

CEO Cancer Gold Standard™

Gold Standard  Employer

Gold Standard Employer Since 2006 | Global Gold Standard Employer Since 2013


At Novartis Oncology, our mission is to discover new ways to improve and extend the lives of people with cancer. This starts with the health of our associates. Our accreditation with the CEO Cancer Gold Standard has provided us for the past 10 years with a valuable framework from which to structure our programs geared toward preventing cancer, providing support during the cancer journey, and encouraging the overall health and well-being of our associates.

— Elizabeth (Liz) Barrett

Gold Standard  Task Force Participation

Gold Standard Co-Chair, Accreditation Review Board Member & Member: Roy D. Baynes, MD, PhD, Senior Vice President & Head of Global Clinical Development, Chief Medical Officer

Global Gold Standard  Task Force Participation

Global Gold Standard Subcommittee Member: Dawn Aubel, EdD, MS, MPH, APNc, Medical Science Liaison Hematology

Life Sciences Consortium

LSC  Task Force Participation

Task Force Member(s): Elizabeth Barrett, Chief Executive Officer, Novartis Oncology; Maya R. Said, Global Head, Oncology Policy and Market Access


Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. For more information, please visit